Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
316.83B | 276.08B | 252.71B | 226.34B | 213.00B | Gross Profit |
68.40B | 63.87B | 57.91B | 51.63B | 40.28B | EBIT |
30.09B | 29.11B | 27.22B | 23.55B | 14.25B | EBITDA |
62.06B | 58.88B | 56.66B | 55.50B | 43.00B | Net Income Common Stockholders |
19.93B | 19.83B | 18.85B | 15.67B | 9.71B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
32.53B | 45.47B | 44.39B | 48.69B | 44.44B | Total Assets |
312.44B | 273.71B | 246.19B | 231.81B | 220.78B | Total Debt |
33.62B | 30.18B | 20.43B | 21.87B | 25.56B | Net Debt |
1.08B | -15.29B | -22.04B | -25.52B | -16.91B | Total Liabilities |
170.35B | 146.68B | 126.89B | 127.18B | 129.81B | Stockholders Equity |
140.68B | 125.75B | 118.12B | 103.53B | 89.96B |
Cash Flow | Free Cash Flow | |||
16.62B | 21.84B | 21.27B | 32.05B | 29.54B | Operating Cash Flow |
28.53B | 40.78B | 38.53B | 43.57B | 40.54B | Investing Cash Flow |
-21.75B | -17.93B | -18.39B | -11.84B | -13.22B | Financing Cash Flow |
-19.67B | -20.80B | -25.73B | -27.30B | -23.62B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥18.71B | 10.30 | 3.59% | 6.35% | 54.17% | ||
76 Outperform | ¥26.88B | 31.60 | ― | 24.84% | -38.04% | ||
73 Outperform | $523.22B | 25.80 | 14.78% | <0.01% | 14.76% | 0.69% | |
70 Outperform | $9.20T | 14.36 | 13.04% | 3.01% | 2.85% | 12.63% | |
68 Neutral | ¥9.53B | 24.97 | 1.29% | 4.70% | 35.62% | ||
66 Neutral | $372.12B | 27.96 | 15.57% | 1.95% | 6.94% | -14.06% | |
61 Neutral | $14.75B | 5.86 | -3.99% | 6.11% | 2.67% | -30.24% |